Latest News for: mps ii
Edit
Rio Grande Sun
16 Dec 2025
Immusoft Secures FDA Orphan Drug Designation for ISP-002 in MPS II, a Progressive Lysosomal Storage Disease
Orphan Drug Designation for MPS II builds on Immusoft's clinical progress in MPS I and supports expansion of its engineered B cell platform across multiple indications ... .
Edit
Denali Therapeutics Announces FDA Review Extension of BLA for Tividenofusp Alfa for the Treatment of MPS II (Hunter Syndrome) (Form 8-K) (Denali Therapeutics Inc)
Public Technologies 14 Oct 2025
) Denali Therapeutics Announces FDA Review Extension of BLA for Tividenofusp Alfa for the Treatment of MPS II (Hunter Syndrome) ... (MPS II), also known as Hunter syndrome ... About Hunter Syndrome (MPS II).
Edit
Denali Therapeutics Announces FDA Review Extension of BLA for Tividenofusp Alfa for the Treatment of MPS II (Hunter Syndrome) (Denali Therapeutics Inc)
Public Technologies 13 Oct 2025
). The text version of this document is not available ... Disclaimer ... (noodl. 126999532) .
- 1